Literature DB >> 17222166

Active sugar transport in health and disease.

E M Wright1, B A Hirayama, D F Loo.   

Abstract

Secondary active glucose transport occurs by at least four members of the SLC5 gene family. This review considers the structure and function of two premier members, SGLT1 and SGLT2, and their role in intestinal glucose absorption and renal glucose reabsorption. Genetics disorders of SGLTs include Glucose-Galactose Malabsorption, and Familial Renal Glucosuria. SGLT1 plays a central role in Oral Rehydration Therapy used so effectively to treat secretory diarrhoea such as cholera. Increasing attention is being focused on SGLTs as drug targets for the therapy of diabetes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17222166     DOI: 10.1111/j.1365-2796.2006.01746.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  164 in total

1.  Persistent disruption of mitochondrial homeostasis after acute kidney injury.

Authors:  Jason A Funk; Rick G Schnellmann
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-07

2.  The structural pathway for water permeation through sodium-glucose cotransporters.

Authors:  Louis J Sasseville; Javier E Cuervo; Jean-Yves Lapointe; Sergei Y Noskov
Journal:  Biophys J       Date:  2011-10-19       Impact factor: 4.033

3.  A tool for multi-scale modelling of the renal nephron.

Authors:  David P Nickerson; Jonna R Terkildsen; Kirk L Hamilton; Peter J Hunter
Journal:  Interface Focus       Date:  2011-03-30       Impact factor: 3.906

4.  Expression of mRNA for glucose transport proteins in jejunum, liver, kidney and skeletal muscle of pigs.

Authors:  J R Aschenbach; K Steglich; G Gäbel; K U Honscha
Journal:  J Physiol Biochem       Date:  2009-09       Impact factor: 4.158

Review 5.  Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.

Authors:  Simon G Patching
Journal:  Mol Neurobiol       Date:  2016-01-22       Impact factor: 5.590

6.  New oral antidiabetic agents.

Authors:  Paolo Cavallo Perin; Paolo Fornengo
Journal:  Intern Emerg Med       Date:  2011-10       Impact factor: 3.397

7.  Cystic fibrosis transmembrane conductance regulator with a shortened R domain rescues the intestinal phenotype of CFTR-/- mice.

Authors:  Lynda S Ostedgaard; David K Meyerholz; Daniel W Vermeer; Philip H Karp; Lindsey Schneider; Curt D Sigmund; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-01       Impact factor: 11.205

Review 8.  SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects.

Authors:  Ele Ferrannini; Anna Solini
Journal:  Nat Rev Endocrinol       Date:  2012-02-07       Impact factor: 43.330

Review 9.  A guide to Ussing chamber studies of mouse intestine.

Authors:  Lane L Clarke
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-02       Impact factor: 4.052

10.  Mesenteric blood flow, glucose absorption and blood pressure responses to small intestinal glucose in critically ill patients older than 65 years.

Authors:  Jennifer A Sim; M Horowitz; M J Summers; L G Trahair; R S Goud; A V Zaknic; T Hausken; J D Fraser; M J Chapman; K L Jones; A M Deane
Journal:  Intensive Care Med       Date:  2012-10-25       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.